POSTTRANSFUSION HYPERHAEMOLYSIS IN A PATIENT WITH SICKLE-CELL DISEASE- USE OF STEROIDS AND INTRAVENOUS IMMUNOGLOBULIN TO PREVENT FURTHER RED-CELL DESTRUCTION
Jo. Cullis et al., POSTTRANSFUSION HYPERHAEMOLYSIS IN A PATIENT WITH SICKLE-CELL DISEASE- USE OF STEROIDS AND INTRAVENOUS IMMUNOGLOBULIN TO PREVENT FURTHER RED-CELL DESTRUCTION, Vox sanguinis, 69(4), 1995, pp. 355-357
Delayed haemolytic transfusion reactions (DHTRs) are seen more frequen
tly in patients with sickle cell disease (SCD) than in other groups of
patients, and are characterised by a positive direct antiglobulin tes
t and the appearance of previously undetected red blood cell (RBC) all
oantibodies in the patient's serum. Recently a syndrome of post-transf
usion hyperhaemolysis has been described in children with SCD, charact
erised by destruction of both autologous and transfused RBCs with nega
tive serological findings: continuation of RBC transfusion exacerbated
haemolysis further. We describe a case of life-threatening posttransf
usion hyperhaemolysis in an adult patient with SCD in whom severe anae
mia necessitated further RBC transfusion, which was successfully perfo
rmed in conjunction with intravenous immunoglobulin. This approach may
be useful in the management of post-transfusion hyperhaemolysis in SC
D as well as in the management of severe DHTRs.